TY - JOUR
T1 - Advances in the Assessment of Disease Activity in Inflammatory Bowel Disease
AU - CAMILLERI, MICHAEL
AU - PROANO, MARITZA
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1989
Y1 - 1989
N2 - Knowledge of the severity and extent of the inflammation in inflammatory bowel diseases provides a means of determining rational therapeutic strategies in affected patients. During the past 3 decades, several clinical, laboratory, and combined indices have been proposed for the assessment of inflammatory bowel disease; refinements in radiologic methods and the availability of endoscopy and biopsy have facilitated the accurate assessment of the extent and severity of the disease. In relapsing conditions such as inflammatory bowel disease, however, the use of such procedures is limited by the radiation exposure or the relatively invasive nature of the technique. In this article, we review the proposed methods and recent advances in assessment of patients with inflammatory bowel disease; we also discuss possible strategies at the time of diagnosis, during recurrence, and in evaluation of the efficacy of drug or dietetic therapy.
AB - Knowledge of the severity and extent of the inflammation in inflammatory bowel diseases provides a means of determining rational therapeutic strategies in affected patients. During the past 3 decades, several clinical, laboratory, and combined indices have been proposed for the assessment of inflammatory bowel disease; refinements in radiologic methods and the availability of endoscopy and biopsy have facilitated the accurate assessment of the extent and severity of the disease. In relapsing conditions such as inflammatory bowel disease, however, the use of such procedures is limited by the radiation exposure or the relatively invasive nature of the technique. In this article, we review the proposed methods and recent advances in assessment of patients with inflammatory bowel disease; we also discuss possible strategies at the time of diagnosis, during recurrence, and in evaluation of the efficacy of drug or dietetic therapy.
UR - http://www.scopus.com/inward/record.url?scp=0024415453&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024415453&partnerID=8YFLogxK
U2 - 10.1016/S0025-6196(12)61753-4
DO - 10.1016/S0025-6196(12)61753-4
M3 - Article
C2 - 2671519
AN - SCOPUS:0024415453
SN - 0025-6196
VL - 64
SP - 800
EP - 807
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 7
ER -